Ouellette R G
Nurse Anesth. 1991 Sep;2(3):134-7.
Midazolam is the first water soluble sedative widely used as an adjunct agent in general anesthesia. This 1,4-benzodiazepine derivative has been found to be a versatile agent, used as a premedicant, a hypnotic, an adjunct to intravenous conscious sedation, a long-term infused sedative agent, and more recently as an induction agent in selected situations. This report provides descriptive observations of midazolam used as an induction agent in 50 American Society of Anesthesiologists class I through III patients undergoing general anesthesia for elective or selected emergency surgeries. All inductions were preceded by 10 to 20 micrograms sufentanil. The use of sufentanil prior to the induction dose of midazolam facilitated a quicker onset of unconsciousness. Induction was smooth but gradual, and the course of anesthesia was otherwise satisfactory. Patients were alert and awake in the postanesthesia care unit. Recovery time was not prolonged due to somnolence or disorientation.
咪达唑仑是第一种广泛用作全身麻醉辅助药物的水溶性镇静剂。这种1,4 - 苯二氮䓬衍生物已被发现是一种用途广泛的药物,用作术前用药、催眠药、静脉清醒镇静辅助药、长期输注镇静剂,最近还在特定情况下用作诱导剂。本报告提供了对50例美国麻醉医师协会I至III级患者使用咪达唑仑作为诱导剂的描述性观察,这些患者接受择期或特定急诊手术的全身麻醉。所有诱导均在10至20微克舒芬太尼之后进行。在咪达唑仑诱导剂量之前使用舒芬太尼有助于更快地进入无意识状态。诱导过程平稳但逐渐进行,麻醉过程的其他方面令人满意。患者在麻醉后护理单元中清醒且警觉。恢复时间未因嗜睡或定向障碍而延长。